Int J Stomatol

Inter J Stomatol ›› 2017, Vol. 44 ›› Issue (6): 636-641.doi: 10.7518/gjkq.2017.06.003

• Microbiology • Previous Articles     Next Articles

Research progress on antitumor effect and mechanism of probiotics

Wang Zhiqiang1,2, Ma Lijuan1,2, Zhou Haijing3, Yang Lan2, Nie Hongbing3, Xue Long2   

  1. 1. School of Stomatology, Lanzhou University, Lanzhou 730000, China;
    2. Dept. of Oral and Maxillofacial Surgery, Second Hospital of Lanzhou University, Lanzhou 730030, China;
    3. Key Laboratory of Oral Diseases of State Ethnic Affairs Commission, Northwest University for Nationalities, Lanzhou 730030, China
  • Received:2016-12-30 Revised:2017-07-15 Online:2017-11-01 Published:2017-11-01
  • Supported by:
    This study was supported by Natural Science Fund of Gansu Province(1506RJZA276).

RichHTML

8

PDF (PC)

474

Abstract: Probiotics are living microorganisms that can elicit probiotic effects on hosts. For example, probiotics induce antitumor effects, which have been widely investigated. This article briefly summarizes the research progress on the mechanism and antitumor effects of probiotics.

Key words: probiotics, anti-tumor, mechanism

CLC Number: 

  • R37

TrendMD: 
[1] Fuller R. Probiotics in man and animal[J]. J Appl Bacteriol, 1989, 66(5):365-378.
[2] Veld JI, Havenaar R, Marteau P. Establishing a scientific basis for probiotic R&D[J]. Trends Biote-chnol, 1994, 12(1):6-8.
[3] Food and Agriculture Organisation of the United Nations, World Health Organisation. Guidelines for the evaluation of probiotics in food[R]. London (Canada): Food and Agriculture Organisation of the United Nations and World Health Organisation, 2002.
[4] Agostoni C, Axelsson I, Goulet O, et al. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutri-tion[J]. J Pediatr Gastroenterol Nutr, 2004, 39(5): 465-473.
[5] Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature[J]. Int J Environ Res Public Health, 2014, 11(5):4745-4767.
[6] Young J, Tardy V, Perrière AL, et al. Probiotics—from metchnikoff to bioactives[J]. Int Dairy J, 2008, 18(7):714-728.
[7] Lichtenstein L, Avni-Biron I, Ben-Bassat O. Probio-tics and prebiotics in Crohn’s disease therapies[J]. Best Pract Res Clin Gastroenterol, 2016, 30(1):81- 88.
[8] Grant MC, Baker JS. An overview of the effect of probiotics and exercise on mood and associated health conditions[J]. Crit Rev Food Sci Nutr, 2016: 1189872.
[9] 郭曼丽, 聂红兵, 周海静. 乳酸杆菌在口腔中益生特性的研究[J]. 重庆医学, 2015, 44(10):1408-1410.
Guo ML, Nie HB, Zhou HJ. Study on probiotic pro-perties of Lactobacillus in oral cavity[J]. Chongqing Med, 2015, 44(10):1408-1410.
[10] 孙小华, 付英. 益生菌与人体健康研究[J]. 中国卫生产业, 2015, 12(21):162-164.
Sun XH, Fu Y. Progress in the human health effects of probiotics[J]. Chin Health Ind, 2015, 12(21):162- 164.
[11] Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer[J]. World J Gastroenterol, 2014, 20(24):7878- 7886.
[12] Plottel CS, Blaser MJ. Microbiome and malignancy [J]. Cell Host Microbe, 2011, 10(4):324-335.
[13] Abreu MT, Peek RM Jr. Gastrointestinal malignancy and the microbiome[J]. Gastroenterology, 2014, 146 (6):1534-1546.
[14] Soltan Dallal MM, Mojarrad M, Baghbani F, et al. Effects of probiotic Lactobacillus acidophilus and Lactobacillus casei on colorectal tumor cells activity (CaCo-2)[J]. Arch Iran Med, 2015, 18(3):167-172.
[15] Chen ZF, Ai LY, Wang JL, et al. Probiotics Clos - tridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis[J]. Future Microbiol, 2015, 10(9):1433-1445.
[16] 梁素妨, 许琳, 王静, 等. 胃癌和结肠癌小肠细菌过度生长情况分析[J]. 中国微生态学杂志, 2015, 27 (12):1417-1420.
Liang SF, Xu L, Wang J, et al. Small intestinal bacterial overgrowth in patients with gastrointestinal cancer[J]. Chin J Microecol, 2015, 27(12):1417- 1420.
[17] Candela M, Turroni S, Biagi E, et al. Inflammation and colorectal cancer, when microbiota-host mutua-lism breaks[J]. World J Gastroenterol, 2014, 20(4): 908-922.
[18] Hardy H, Harris J, Lyon E, et al. Probiotics, prebio-tics and immunomodulation of gut mucosal defences: homeostasis and immunopathology[J]. Nutrients, 2013, 5(6):1869-1912.
[19] Romano M, Ricci V, Zarrilli R. Mechanisms of disease: Helicobacter pylori -related gastric carcino-genesis—implications for chemoprevention[J]. Nat Clin Pract Gastroenterol Hepatol, 2006, 3(11):622- 632.
[20] 杨茜洋, 王绪明. 乳腺癌的风险评估及治疗[J]. 江汉大学学报(自然科学版), 2016, 44(2):179-183.
Yang QY, Wang XM. Risk assessment and treatment of breast cancer[J]. J Jianghan Univ(Nat Sci Ed), 2016, 44(2):179-183.
[21] 张红霞. 乳腺癌术后患者生活质量的影响因素分析[J]. 解放军护理杂志, 2007, 24(3):45-46.
Zhang HX. Influencing factors of quality of life in patients with breast cancer after operation[J]. Nurs J Chin PLA, 2007, 24(3):45-46.
[22] Hassan Z, Mustafa S, Rahim RA, et al. Anti-breast cancer effects of live, heat-killed and cytoplasmic fractions of Enterococcus faecalis and Staphyloco - ccus hominis isolated from human breast milk[J]. In Vitro Cell Dev Biol Anim, 2016, 52(3):337-348.
[23] Aragón F, Carino S, Perdigón G, et al. The adminis-tration of milk fermented by the probiotic Lacto-bacillus casei CRL 431 exerts an immunomodula-tory effect against a breast tumour in a mouse model [J]. Immunobiology, 2014, 219(6):457-464.
[24] Motevaseli E, Shirzad M, Akrami SM, et al. Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate [J]. J Med Microbiol, 2013, 62(Pt 7):1065-1072.
[25] de Moreno de LeBlanc A, Matar C, Farnworth E, et al. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir[J]. Cyto-kine, 2006, 34(1/2):1-8.
[26] De MA, Matar C, Thériault C, et al. Effects of milk fermented by Lactobacillus helveticus R389 on im-mune cells associated to mammary glands in normal and a breast cancer model[J]. Immunobiology, 2005, 210(5):349-358.
[27] Zoa-Assoumou S, Ndjoyi-Mbiguino A, Mabika BM, et al. Human papillomavirus genotypes distribution in cervical cancer cases in Gabon[J]. Infect Agent Cancer, 2016, 11(1):42.
[28] Zoa-Assoumou S, Ndjoyi-Mbiguino A, Mabika MB, et al. Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities[J]. Infect Agent Cancer, 2016, 11(1):2.
[29] Nami Y, Abdullah N, Haghshenas B, et al. Assess-ment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL[J]. Microbiol Immunol, 2014, 58(9): 492-502.
[30] 肖世全, 张培炽, 田玉静. 以卡铂或顺铂为主联合化疗治疗晚期肺癌疗效及毒性比较[J]. 中国肿瘤临床与康复, 1996(s1):57-59.
Xiao SQ, Zhang PZ, Tian YJ. Comparison of effi-cacy and toxicity of carboplatin combined with cis-platin in the treatment of advanced lung cancer[J]. Chin J Clin Oncol Rehab, 1996(s1):57-59.
[31] 张梅春, 胡成平. 肺癌顺铂耐药的分子机制[J]. 国际呼吸杂志, 2006, 26(2):152-155.
Zhang MC, Hu CP. The molecular basis for cisplatin resistance in lung cancer[J]. Int J Resp, 2006, 26(2): 152-155.
[32] Gui QF, Lu HF, Zhang CX, et al. Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model[J]. Genet Mol Res, 2015, 14(2):5642-5651.
[33] Gollwitzer ES, Marsland BJ. Microbiota abnorma-lities in inflammatory airway diseases—potential for therapy[J]. Pharmacol Ther, 2014, 141(1):32-39.
[34] Mortaz E, Adcock IM, Folkerts G, et al. Probiotics in the management of lung diseases[J]. Mediators Inflamm, 2013(7350):751068.
[35] Bosch M, Nart J, Audivert S, et al. Isolation and characterization of probiotic strains for improving oral health[J]. Arch Oral Biol, 2012, 57(5):539-549.
[36] 钟来平, 孙坚, 郭伟, 等. 256例局部晚期口腔癌的生存分析[J]. 中国肿瘤临床, 2015, 42(4):217-221.
Zhang LP, Sun J, Guo W, et al. Survival analysis of 256 patients with oral cancer[J]. Chin J Clin Oncol, 2015, 42(4):217-221.
[37] Zhang M, Wang F, Jiang L, et al. Lactobacillus sa - livarius REN inhibits rat oral cancer induced by 4- nitroquioline 1-oxide[J]. Cancer Prev Res(Phila), 2013, 6(7):686-694.
[38] Maekawa T, Hajishengallis G. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss[J]. J Periodontal Res, 2014, 49(6):785-791.
[39] 李博磊, 李龙江, 周学东, 等. 口腔微生物与口腔癌[J]. 口腔医学研究, 2015(6):558-563.
Li BL, Li LJ, Zhou XD, et al. Oral microorganisms and oral cancer[J]. J Oral Sci Res, 2015(6):558-563.
[40] Yang H, Zhao X, Tang S, et al. Probiotics reduce psychological stress in patients before laryngeal can-cer surgery[J]. Asia Pac J Clin Oncol, 2016, 12(1):e92-e96.
[41] Dimitrovski D, Cencic A, Winkelhausen EA. Lacto - bacillus plantarum extracellular metabolites: in vitro assessment of probiotic effects on normal and cance-rogenic human cells[J]. Inter Dairy J, 2014, 39(2): 293-300.
[42] Ki Y, Kim W, Nam J, et al. Probiotics for rectal volume variation during radiation therapy for pros-tate cancer[J]. Int J Radiat Oncol Biol Phys, 2013, 87(4):646-650.
[43] Ray K. Diagnosis: programmed probiotics light up liver cancer in urine[J]. Nat Rev Gastroenterol Hepa-tol, 2015, 12(8):429.
[44] Mandair DS, Rossi RE, Pericleous M, et al. The im-pact of diet and nutrition in the prevention and pro-gression of hepatocellular carcinoma[J]. Expert Rev Gastroenterol Hepatol, 2014, 8(4):369-382.
[45] Mandair D, Rossi RE, Pericleous M, et al. Prostate cancer and the influence of dietary factors and sup-plements: a systematic review[J]. Nutr Metab(Lond), 2014, 11(1):30.
[46] Kukkonen K, Kuitunen M, Haahtela T, et al. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases[J]. Pediatr Allergy Im-munol, 2010, 21(1 Pt 1):67-73.
[47] Dong H, Rowland I, Tuohy KM, et al. Selective ef-fects of Lactobacillus casei Shirota on T cell activa-tion, natural killer cell activity and cytokine produc-tion[J]. Clin Exp Immunol, 2010, 161(2):378-388.
[48] Iyer C, Kosters A, Sethi G, et al. Probiotic Lacto - bacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modula-tion of NF-kappaB and MAPK signalling[J]. Cell Microbiol, 2008, 10(7):1442-1452.
[49] Maroof H, Hassan ZM, Mobarez AM, et al. Lacto - bacillus acidophilus could modulate the immune response against breast cancer in murine model[J]. J Clin Immunol, 2012, 32(6):1353-1359.
[50] Hu J, Wang C, Ye L, et al. Anti-tumour immune effect of oral administration of Lactobacillus plan - tarum to CT26 tumour-bearing mice[J]. J Biosci, 2015, 40(2):269-279.
[51] Lammers KM, Brigidi P, Vitali B, et al. Immunomo-dulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononu-clear cells[J]. FEMS Immunol Med Microbiol, 2003, 38(2):165-172.
[52] Peterson CT, Sharma V, Elmén L, et al. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota[J]. Clin Exp Immunol, 2015, 179(3):363-377.
[53] Lakritz JR, Poutahidis T, Levkovich T, et al. Bene-ficial bacteria stimulate host immune cells to coun-teract dietary and genetic predisposition to mammary cancer in mice[J]. Inter J Cancer, 2014, 135(3):529- 540.
[54] Ghoneim MA, Moselhy SS. Antioxidant status and hormonal profile reflected by experimental feeding of probiotics[J]. Toxicol Ind Health, 2016, 32(4): 741-750.
[55] Nébot-Vivinus M, Harkat C, Bzioueche H, et al. Multispecies probiotic protects gut barrier function in experimental models[J]. World J Gastroenterol, 2014, 20(22):6832-6843.
[56] Burns AJ, Rowland IR. Antigenotoxicity of pro-biotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells[J]. Mutat Res, 2004, 551(1/2):233-243.
[57] Zhu K, Hölzel CS, Cui Y, et al. Probiotic bacillus cereus strains, a potential risk for public health in China[J]. Front Microbiol, 2016, 7(560):718.
[58] Floch MH. Probiotic safety and risk factors[J]. J Clin Gastroenterol, 2013, 47(5):375-376.
[1] Yu Lerong,Li Xiangwei,Ai Hong. Research progress on the stemness maintenance of dental pulp stem cells [J]. Int J Stomatol, 2023, 50(4): 463-471.
[2] Wang Jingyan,Qin Man,Wang Xin.. Research progress on the clinical characteristics of Axenfeld-Rieger syndrome and the pathogenic mechanisms of paired-like homeodomain transcription factor 2 mutations [J]. Int J Stomatol, 2023, 50(2): 224-229.
[3] Gong Tao,Li Yuqing,Zhou Xuedong.. Research progress on sugar transporter and regulatory mechanisms in Streptococcus mutans [J]. Int J Stomatol, 2022, 49(5): 506-510.
[4] Zhao Manzhu,Song Jinlin. Research progress on expression distribution and regulation mechanism of clock genes in tooth development [J]. Int J Stomatol, 2022, 49(4): 380-385.
[5] Li Junlin,Xiao Liwei. Research progress on the mechanism and efficacy of molar distalization with clear aligner technique [J]. Int J Stomatol, 2022, 49(1): 109-115.
[6] Jia Leming,Jia Xiaoyue,Yang Ran,Zhou Xuedong,Xu Xin. Progress on the application of probiotics in the management of periodontal diseases [J]. Int J Stomatol, 2020, 47(5): 515-521.
[7] Yang Peipei,Yang Yuchen,Zhang Qiang. Advances in the mechanism and effect of nicotine on alveolar osteoclasts [J]. Int J Stomatol, 2020, 47(5): 616-620.
[8] Liu Lin,Zhou Jieyu,Wu Yafei,Zhao Lei. Application of probiotic ecological regulation in prevention and treatment of periodontal diseases [J]. Int J Stomatol, 2020, 47(2): 131-137.
[9] Huang Xiaoyu,Li Mingyun,Zhou Xue- dong,Cheng Lei. Effects of systemic and local factors on microbial homeostasis around implants [J]. Int J Stomatol, 2019, 46(6): 730-734.
[10] Hao Fu,Sun Rui. Research progress on second primary carcinoma of head and neck squamous cell carcinoma [J]. Int J Stomatol, 2019, 46(5): 585-592.
[11] Liu Dan, Ren Biao, Cheng Lei.. Research development of silver nanoparticle on prevention and treatment of oral infectious disease [J]. Inter J Stomatol, 2018, 45(4): 408-413.
[12] Ji Ning, Zhao Hang, Zeng Xin, Chen Qianming. Research progress on nucleoside drugs against herpes virus [J]. Inter J Stomatol, 2018, 45(3): 351-357.
[13] Liu Caiyun, Tao Yiran. Correlation between taste injury and diabetes [J]. Inter J Stomatol, 2018, 45(3): 358-361.
[14] Wang Maoxia, Dai Guanyu, Meng Yukun. Mechanism of vertical food impaction [J]. Inter J Stomatol, 2018, 45(2): 245-248.
[15] Tang Qiuling, Li Gege, Pan Jiahui, Hou Yubo, Meng Yang, Yu Weixian.. Mechanism of pyroptosis and Porphyromonas gingivalis in periodontitis development process [J]. Inter J Stomatol, 2017, 44(6): 660-663.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .